CME credit is not offered for this activity.

This content is provided to members of SVS for free as a member benefit. If you are not a current member of SVS, click here for information on how to apply for membership.

Summary
In this video presentation, we showcase our current approach to physician-modified endografting and provide insights into mid-term clinical outcomes. The data presented are derived from a consecutive series of 50 cases involving juxta-renal abdominal aortic aneurysms, where fenestration design was determined through three-dimensional model-assisted planning, and the deployment of the fenestrated device is assisted by intra-operative three-dimensional image analysis using cone beam CT. The method demonstrated satisfactory results in fenestration-branch alignment accuracy (100%). Kaplan-Meier analysis revealed mid-term outcomes (at 4 postoperative years) with a cumulative occurrence of >5 mm shrinkage (73%, 95% C.I.: 58.6-86.2%), freedom from >5 mm sac enlargement (97.2%, 95% CI: 56.7-81.9%), and assisted patency of renal bridging stents (100%).

Authors
Submitting & Presenting Author: Hiroshi Mitsuoka, MD, PhD
Co-Author: Yasuhiko Terai 
Co-Author: Takahiro Suzuki, MD

Target Audience
All members of the vascular surgery field.

Price
SVS Member: Free
Non-Member: $35

Original video presented at VAM 2024

SVS Disclaimer
The opinions or views expressed on the SVS OnDemand platform are those of the faculty and do not necessarily reflect the opinions, recommendations, or endorsement of SVS. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of SVS faculty who are willing to share such information with colleagues. The SVS disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services and events.